Prostate Cancer and Prostatic Diseases - Table of Contents alert Volume 20 Issue 3

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 20, Issue 3 (September 2017) In this issue Reviews Original Articles Also new AOP Sign up for e-alerts Twitter Recommend to your library Web feed Subscribe Advertisement Celebrating 20 years of Prostate Cancer and Prostatic Diseases — 1997 to 2017 Thank you to the editors, board members, contributors, reviewers and readers, past and present for their invaluable contributions, and for bringing the journal to this milestone.  Watch our anniversary video showing a brief impact overview >>>      Reviews Top Extracellular vesicles for liquid biopsy in prostate cancer: where are we and where are we headed? OPEN V R Minciacchi, A Zijlstra, M A Rubin and D Di Vizio Prostate Cancer Prostatic Dis 2017 20: 251-258; advance online publication, April 4, 2017; 10.1038/pcan.2017.7 Abstract | Full Text Androgen deprivation therapy for prostate cancer and dementia risk: a systematic review and meta-analysis K T Nead, S Sinha and P L Nguyen Prostate Cancer Prostatic Dis 2017 20: 259-264; advance online publication, March 28, 2017; 10.1038/pcan.2017.10 Abstract | Full Text A review of pomegranate in prostate cancer C J Paller, A Pantuck and M A Carducci Prostate Cancer Prostatic Dis 2017 20: 265-270; advance online publication, April 25, 2017; 10.1038/pcan.2017.19 Abstract | Full Text Original Articles Top ProPSA and the Prostate Health Index as predictive markers for aggressiveness in low-risk prostate cancer—results from an international multicenter study I Heidegger, H Klocker, R Pichler, A Pircher, W Prokop, E Steiner, C Ladurner, E Comploj, A Lunacek, D Djordjevic, A Pycha, E Plas, W Horninger and J Bektic Prostate Cancer Prostatic Dis 2017 20: 271-275; advance online publication, March 21, 2017; 10.1038/pcan.2017.3 Abstract | Full Text Impact of symptomatic skeletal events on health-care resource utilization and quality of life among patients with castration-resistant prostate cancer and bone metastases R McKay, B Haider, M S Duh, A Valderrama, M Nakabayashi, M Fiorillo, L Ristovska, L Wen and P Kantoff Prostate Cancer Prostatic Dis 2017 20: 276-282; advance online publication, February 21, 2017; 10.1038/pcan.2017.4 Abstract | Full Text Contemporary management of men with high-risk localized prostate cancer in the United States A B Weiner, R S Matulewicz, E M Schaeffer, S L Liauw, J M Feinglass and S E Eggener Prostate Cancer Prostatic Dis 2017 20: 283-288; advance online publication, June 20, 2017; 10.1038/pcan.2017.5 Abstract | Full Text Imaging response during therapy with radium-223 for castration-resistant prostate cancer with bone metastases—analysis of an international multicenter database D Keizman, M O Fosboel, H Reichegger, A Peer, E Rosenbaum, M-C Desax, V Neiman, P M Petersen, J Mueller, R Cathomas, M Gottfried, H Dresler, D Sarid, W Mermershtain, K Rouvinov, J Mortensen, S Gillessen, G Daugaard and A Omlin Prostate Cancer Prostatic Dis 2017 20: 289-293; advance online publication, February 28, 2017; 10.1038/pcan.2017.6 Abstract | Full Text Patient selection for prostate focal therapy in the era of active surveillance: an International Delphi Consensus Project K J Tay, M J Scheltema, H U Ahmed, E Barret, J A Coleman, J Dominguez-Escrig, S Ghai, J Huang, J S Jones, L H Klotz, C N Robertson, R Sanchez-Salas, S Scionti, A Sivaraman, J de la Rosette and T J Polascik Prostate Cancer Prostatic Dis 2017 20: 294-299; advance online publication, March 28, 2017; 10.1038/pcan.2017.8 Abstract | Full Text Impact of urologists’ ownership of radiation equipment in the treatment of prostate cancer S B Williams, J Huo, B F Chapin, B D Smith and K E Hoffman Prostate Cancer Prostatic Dis 2017 20: 300-304; advance online publication, March 28, 2017; 10.1038/pcan.2017.9 Abstract | Full Text Total and beverage-specific alcohol intake and the risk of aggressive prostate cancer: a case–control study N P Papa, R J MacInnis, H Jayasekara, D R English, D Bolton, I D Davis, N Lawrentschuk, J L Millar, J Pedersen, G Severi, M C Southey, J L Hopper and G G Giles Prostate Cancer Prostatic Dis 2017 20: 305-310; advance online publication, April 18, 2017; 10.1038/pcan.2017.12 Abstract | Full Text Magnetic resonance imaging targeted transperineal prostate biopsy: a local anaesthetic approach E J Bass, I A Donaldson, A Freeman, C Jameson, S Punwani, C Moore, M Arya, M Emberton and H U Ahmed Prostate Cancer Prostatic Dis 2017 20: 311-317; advance online publication, May 9, 2017; 10.1038/pcan.2017.13 Abstract | Full Text Reduced prostate cancer risk with green tea and epigallocatechin 3-gallate intake among Hong Kong Chinese men P M Y Lee, C F Ng, Z M Liu, W M Ho, M K Lee, F Wang, H D Kan, Y H He, S S M Ng, S Y S Wong and L A Tse Prostate Cancer Prostatic Dis 2017 20: 318-322; advance online publication, April 18, 2017; 10.1038/pcan.2017.18 Abstract | Full Text Does mpMRI improve clinical criteria in selecting men with prostate cancer for active surveillance? K J Tay, R T Gupta, J Holtz, R K Silverman, E Tsivian, A Schulman, J W Moul and T J Polascik Prostate Cancer Prostatic Dis 2017 20: 323-327; advance online publication, April 25, 2017; 10.1038/pcan.2017.20 Abstract | Full Text Long-term allopurinol use decreases the risk of prostate cancer in patients with gout: a population-based study H-J Shih, M-C Kao, P-S Tsai, Y-C Fan and C-J Huang Prostate Cancer Prostatic Dis 2017 20: 328-333; advance online publication, April 11, 2017; 10.1038/pcan.2017.14 Abstract | Full Text Trends in the use of radiation therapy for stage IIA prostate cancer from 2004 to 2013: a retrospective analysis using the National Cancer Database T Malouff, N W Mathy, S Marsh, R W Walters and P T Silberstein Prostate Cancer Prostatic Dis 2017 20: 334-338; advance online publication, April 11, 2017; 10.1038/pcan.2017.15 Abstract | Full Text Longitudinal assessment of urinary PCA3 for predicting prostate cancer grade reclassification in favorable-risk men during active surveillance J J Tosoian, H D Patel, M Mamawala, P Landis, S Wolf, D J Elliott, J I Epstein, H B Carter, A E Ross, L J Sokoll and C P Pavlovich Prostate Cancer Prostatic Dis 2017 20: 339-342; advance online publication, April 18, 2017; 10.1038/pcan.2017.16 Abstract | Full Text Association of comorbid disease burden at diagnosis with higher tumor grade in men with non-metastatic prostate cancer T J Daskivich, C J Dru, D Skarecky, T Ahlering and S J Freedland Prostate Cancer Prostatic Dis 2017 20: 343-347; advance online publication, April 25, 2017; 10.1038/pcan.2017.22 Abstract | Full Text Multiparametric MRI/ultrasound fusion-guided biopsy decreases detection of indolent cancer in African-American men M Kongnyuy, M M Siddiqui, A K George, A Muthigi, A Sidana, M Maruf, B Turkbey, P L Choyke, B J Wood and P A Pinto Prostate Cancer Prostatic Dis 2017 20: 348-351; advance online publication, April 25, 2017; 10.1038/pcan.2017.21 Abstract | Full Text Lutetium-177-labelled anti-prostate-specific membrane antigen antibody and ligands for the treatment of metastatic castrate-resistant prostate cancer: a systematic review and meta-analysis R J S Calopedos, V Chalasani, R Asher, L Emmett and H H Woo Prostate Cancer Prostatic Dis 2017 20: 352-360; advance online publication, April 25, 2017; 10.1038/pcan.2017.23 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Prostate Cancer and Prostatic Diseases. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.